BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26346357)

  • 1. [Therapy-related myelodysplastic syndrome as a late adverse event of definitive chemoradiotherapy for esophageal and oropharyngeal cancer].
    Kamihara Y; Sato Y; Takada K; Okagawa Y; Iyama S; Sato T; Miyanishi K; Takimoto R; Kobune M; Kato J
    Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1664-73. PubMed ID: 26346357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report.
    Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Nakayama N; Miyazaki K
    Eur J Gynaecol Oncol; 2014; 35(4):443-8. PubMed ID: 25118489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
    J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T; Yasuyama M; Kawauchi K
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
    Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary myelodysplastic syndrome after small cell lung cancer and esophageal cancer.
    Otsuka Y; Konishi T; Nara S; Furushima K; Nakajima K; Shimada H
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1318-21. PubMed ID: 16105115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndrome in a child with a history of medulloblastoma.
    Akyüz C; Emir S; Güler N; Tüker A; Büyükpamukçu M
    Turk J Pediatr; 1998; 40(1):131-4. PubMed ID: 9673540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancer.
    Monma S; Kato K; Shouji H; Okita N; Takashima A; Honma Y; Iwasa S; Hamaguchi T; Yamada Y; Shimada Y; Boku N; Nagashima K; Ito Y; Itami J
    Esophagus; 2019 Oct; 16(4):402-407. PubMed ID: 31222680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
    Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
    J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.
    Kantarjian HM; Keating MJ; Walters RS; Smith TL; Cork A; McCredie KB; Freireich EJ
    J Clin Oncol; 1986 Dec; 4(12):1748-57. PubMed ID: 3783201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer.
    Roman-Unfer S; Bitran JD; Hanauer S; Johnson L; Rita D; Booth C; Chen K
    Bone Marrow Transplant; 1995 Jul; 16(1):163-8. PubMed ID: 7581117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of therapy-related myelodysplastic syndrome after concurrent oral cancer chemoradiotherapy].
    Doi K; Asano T; Kinoshita T
    Nihon Jibiinkoka Gakkai Kaiho; 2010 Jun; 113(6):556-60. PubMed ID: 20653195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic Syndrome Occurring in a Patient with Gorlin Syndrome.
    Mull JL; Madden LM; Bayliss SJ
    Pediatr Dermatol; 2016 Jul; 33(4):e256-7. PubMed ID: 27241746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features.
    Au WY; Lam CC; Ma ES; Man C; Wan T; Kwong YL
    Hum Pathol; 2001 Jan; 32(1):126-9. PubMed ID: 11172306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Snijder S; Mellink CH; van der Lelie H
    Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related myelodysplastic syndrome with trisomy 1q due to der(1;7) and megakaryoblastic proliferation developing during complete remission of therapy-related acute myeloid leukemia with t(8;21).
    Sakai C; Matsubayashi K; Saotome T; Ishii A; Kumagai K
    Intern Med; 2004 Jul; 43(7):582-6. PubMed ID: 15335185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I; Rigal-Huguet F; Vekhoff A; Desablens B; Bordessoule D; Mounier C; Ferrant A; Sanz M; Fey M; Chomienne C; Chevret S; Degos L; Fenaux P;
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.
    Levine EG; Bloomfield CD
    Semin Oncol; 1992 Feb; 19(1):47-84. PubMed ID: 1736370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemia].
    Iizuka H; Yoshimi A; Yamamoto G; Masuda A; Nannya Y; Ichikawa M; Yatomi Y; Kurokawa M
    Rinsho Ketsueki; 2013 May; 54(5):468-72. PubMed ID: 23727686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.